Skip to content

Indivior Pharmaceuticals, Inc. INDV Increase (Decrease) in Other Operating Assets

Increase (Decrease) in Other Operating Assets at other companies

MYR Group logo
MYR GroupMYRG
-$2.96M+68.9%
NNN REIT logo
NNN REITNNN
$792K+160%
Piper Sandler logo
Piper SandlerPIPR
$2.66M-96.0%
LKQ logo
LKQLKQ
$23M+91.7%
CHE
ChemedCHE
$3.6M+219%
Travel + Leisure logo
Travel + LeisureTNL
-$27M-35.0%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's increase (decrease) in other operating assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's increase (decrease) in other operating assets?
Indivior Pharmaceuticals, Inc. (INDV) reported increase (decrease) in other operating assets of $18M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's increase (decrease) in other operating assets changed year-over-year?
Indivior Pharmaceuticals, Inc. 's increase (decrease) in other operating assets decreased by 0.0% year-over-year, from $18M to $18M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's increase (decrease) in other operating assets?
Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's increase (decrease) in other operating assets has grown at a -15.7% compound annual growth rate (CAGR), from -$69M to -$49M.
What does increase (decrease) in other operating assets mean?
This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.